UMIN ID: UMIN000002146
Registered date:01/07/2009
Effect of omalizumab on FeNO in patients with severe bronchial asthma
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Severe persistent brochial asthma |
Date of first enrollment | 2009/07/01 |
Target sample size | 20 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | FeNO |
---|---|
Secondary Outcome | Score of asthma control test |
Key inclusion & exclusion criteria
Age minimum | 16years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Pregnat women and patients whose weight is less than 30kg. |
Related Information
Primary Sponsor | Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Ministry of Health, Labour and Welfare |
Secondary ID(s) |
Contact
public contact | |
Name | Tamotsu Ishizuka |
Address | Japan |
Telephone | 027-220-8123 |
Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |
scientific contact | |
Name | Tamotsu Ishizuka |
Address | 3-39-15 Showa-machi, 371-8511 Japan Japan |
Telephone | 027-220-8123 |
Affiliation | Gunma University Graduate School of Medicine Departmnet of Medicine and Molecular Science |